Population
p50 knockout mice, interferon type I receptor knockout mice, double-knockout mice, and murine embryonic…
Comparison
Murine encephalomyocarditis virus (EMCV) infection vs Wild-type mice and normal MEFs infected with EMCV
Design
Preclinical
Authors
Loading...
Does not inform clinical management of viral myocarditis; leaves open whether p50 inhibition enhances clearance in humans.
Suppression of apoptosis by NF-kappaB1 (p50) is required for encephalomyocarditis virus virulence in vivo, and its absence allows rapid apoptosis and viral clearance.
Schwarz et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: